General Announcement::Tender Offer & Consent Solicitation-2 percent.Resettable Onward Starting Equity-linked Securities

Issuer & Securities

Issuer/ Manager
GLENMARK PHARMACEUTICALS LIMITED
Securities
GLENMARK PHARM US$170M2%220628 - XS1426780125 - 4G8B
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
19-Mar-2021 09:08:28
Status
New
Announcement Sub Title
Tender Offer & Consent Solicitation-2 percent.Resettable Onward Starting Equity-linked Securities
Announcement Reference
SG210319OTHR5VPM
Submitted By (Co./ Ind. Name)
Glenmark Pharmaceuticals Limited
Designation
Company Secretary and Compliance Officer
Effective Date and Time of the event
19/03/2021 00:00:00
Description (Please provide a detailed description of the event in the box below)
The Issuer wishes to announce today an invitation to the holders of the Notes to tender any and all Bonds for purchase for cash and to approve certain modifications to the terms and conditions of the Bonds in accordance with the procedures described herein, and upon the terms and subject to the conditions set forth in the tender offer and solicitation memorandum (the Tender Offer and Solicitation Memorandum ) and subject to the offer restrictions referred to in the Offer and Distribution Restrictions in the Tender Offer and Solicitation Memorandum.

Attachments

SGX_LAUNCH.pdf
Total size =152K